SAMANTHA BALTAZAR: Open Payments
NPI 1578176475 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 11 payments from 8 companies in 2025. Trend: 2023 $449 · 2024 $805 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $78 |
| ABBVIE INC. | 2 | $61 |
| Boston Scientific Corporation | 1 | $52 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| Eton Pharmaceuticals, Inc. | 1 | $26 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $21 |
Products named: MAVYRET, TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial), REZDIFFRA, Bylvay, GALZIN, Livmarli, RAYALDEE.
Industry payments across CA — which companies pay providers there.
